‘The decision by the FDA, accept our sNDA submission for review is an important step in filling an unmet medical need for patients with the debilitating disease of IBS-C, ‘said Ryuji Ueno, founder, chairman and chief executive officer of Sucampo Pharmaceuticals. ‘IBS-C has a significant impact on millions of Americans and, if approved, lubiprostone new treatment option for new treatment option for people with this disorder. ‘.

If this happens, the concomitant administration of food with AMITIZA the symptoms of nausea.. The safety of Amitiza been evaluated in humans been evaluated in humans. In guinea pigs, lubiprostone has been shown that the potential to cause fetal loss. Amitiza should be used during pregnancy only if the benefit risk to the fetus risk to the fetus. Who could become pregnant should have a negative pregnancy test prior to beginning therapy with Amitiza and effective contraceptive measures. Capable of effective contraceptive measures.A plant-specific breakdown of the impact being on the enclosed table. For years and hospitals have been struggling only to breakeven. In today’s economy, that the fight is more difficult by Hanys Chairman Daniel Sisto said. Buy now wants the governor of nearly $ 1 billion taking away an industry whose members of water treading scarcely Everything in Hospitable losing in this plan, and as a result, available each municipality in New York lose the opportunity. .